Open access
Open access
Powered by Google Translator Translator

Otolaryngology

Therapies for Olfactory Dysfunction — an Update.

7 Feb, 2022 | 08:29h | UTC

Therapies for Olfactory Dysfunction — an Update – Current Allergy and Asthma Reports (if the link is paywalled, try this one)

 


M-A of 26 observational studies found hearing loss and dual sensory loss are linked to excess all-cause and cardiovascular mortality.

3 Feb, 2022 | 08:22h | UTC

Associations of Hearing Loss and Dual Sensory Loss With Mortality: A Systematic Review, Meta-analysis, and Meta-regression of 26 Observational Studies With 1 213 756 Participants – JAMA Otolaryngology—Head & Neck Surgery (link to abstract – $ for full-text)

Author Interview: Associations of Hearing Loss and Dual Sensory Loss With Mortality

 


[Preprint] High prevalence of olfactory disorders 18 months after contracting COVID-19.

26 Jan, 2022 | 02:11h | UTC

High prevalence of olfactory disorders 18 months after contracting COVID-19 – medRxiv

Commentaries:

Half of first-wave Covid cases may have lasting harm to sense of smell – The Guardian

Prevalence of olfactory dysfunction 18 months after SARS-CoV-2 infection – News Medical

 


Systematic Review: Oral antihistamine‐decongestant‐analgesic combinations for the common cold.

26 Jan, 2022 | 01:31h | UTC

Oral antihistamine‐decongestant‐analgesic combinations for the common cold – Cochrane Library

Commentary: Oral antihistamine-decongestant-analgesic combinations for the common cold – Cochrane Library

 


RCT: Endoscopic sinus surgery with medical therapy vs. medical therapy alone for chronic rhinosinusitis with nasal polyps.

12 Jan, 2022 | 08:51h | UTC

Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Systematic Review: Antibiotics for adults and children with sore throats.

10 Dec, 2021 | 10:02h | UTC

Summary: Antibiotics for adults and children with sore throats – Cochrane Library

Original Research: Antibiotics for treatment of sore throat in children and adults – Cochrane Library

 


Choosing Wisely: Nine pediatric otolaryngology recommendations.

9 Nov, 2021 | 01:09h | UTC

Choosing Wisely Canada – pediatric otolaryngology recommendations – Journal of Otolaryngology – Head & Neck Surgery

See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada

 


Retrospective cohort study: corticosteroid treatment linked to lower odds of surgical drainage among pediatric patients with retropharyngeal and parapharyngeal abscesses.

28 Oct, 2021 | 09:52h | UTC

Corticosteroids in the Treatment of Pediatric Retropharyngeal and Parapharyngeal Abscesses – Pediatrics

 


Clinical Report | Topical nasal decongestant Oxymetazoline: safety considerations for perioperative pediatric use.

6 Oct, 2021 | 10:01h | UTC

Topical Nasal Decongestant Oxymetazoline: Safety Considerations for Perioperative Pediatric Use – Pediatrics

 


AHA Scientific Statement: Sleep‐disordered breathing and cardiovascular disease in children and adolescents.

23 Sep, 2021 | 10:02h | UTC

Sleep‐Disordered Breathing and Cardiovascular Disease in Children and Adolescents: A Scientific Statement From the American Heart Association – Journal of the American Heart Association

News release: Obstructive sleep apnea is common in kids and may impact blood pressure, heart health – American Heart Association

 


RCT: Prophylactic steroids prevent hypocalcemia and voice dysfunction in patients undergoing thyroidectomy.

15 Sep, 2021 | 08:44h | UTC

Use of Prophylactic Steroids to Prevent Hypocalcemia and Voice Dysfunction in Patients Undergoing Thyroidectomy: A Randomized Clinical Trial – JAMA Otolaryngology – Head & Neck Surgery (link to abstract – $ for full-text)

Author interview: Prophylactic Steroids for Postthyroidectomy Hypocalcemia and Voice Dysfunction

Commentary: IV Steroid Before Thyroidectomy Prevents Complications — One dose of dexamethasone reduced hypocalcemia, voice issues – MedPage Today (free registration required)

 

Commentary on Twitter

 


Differentiating central from peripheral causes of acute vertigo in an emergency setting with the HINTS, STANDING, and ABCD2 tests: A diagnostic cohort study.

6 Sep, 2021 | 10:36h | UTC

Differentiating central from peripheral causes of acute vertigo in an emergency setting with the HINTS, STANDING, and ABCD2 tests: A diagnostic cohort study – Academic Emergency Medicine (link to abstract – $ for full-text)

Commentary: Can We Detect Central Vertigo on Exam? – Journal Feed

 


Study: Macrolide use significantly associated with both prevalent and incident tinnitus.

22 Aug, 2021 | 22:11h | UTC

Macrolide-associated ototoxicity: a cross-sectional and longitudinal study to assess the association of macrolide use with tinnitus and hearing loss – Journal of Antimicrobial Chemotherapy

Commentary: Macrolide Use and Tinnitus: A New Safety Ringtone? – NEJM Journal Watch (free for a limited period)

 


ASCO Guideline: Salivary gland hypofunction and/or xerostomia induced by nonsurgical cancer therapies.

19 Aug, 2021 | 08:50h | UTC

Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline – Journal of Clinical Oncology

 


Clinical Picture: Mucormycosis after COVID-19 in a patient with diabetes.

6 Aug, 2021 | 10:09h | UTC

Mucormycosis after COVID-19 in a patient with diabetes – The Lancet

Related:

COVID-19 and mucormycosis superinfection: the perfect storm.

ECMM/ISHAM recommendations for clinical management of COVID -19 associated mucormycosis in low- and middle-income countries.

The “Black Fungus” in India: The Emerging Syndemic of COVID-19–Associated Mucormycosis – careful use of antibiotics and corticosteroids and closely monitoring blood glucose levels are some of the strategies suggested by the authors.

Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India – Uncontrolled diabetes mellitus was the most common underlying disease; improper glucocorticoid use was independently associated with the disease.

Opinion | “Doctors have been blamed for the rise in black fungus in India, but the COVID treatment guidelines could be contributing” – improper use of antibiotics and higher than usual doses of corticosteroids may be contributing to the emergence of mucormycosis and other fungal co-infections.

What is mucormycosis, the fungal infection affecting COVID patients in India?

[Preprint] The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries.

Mucormycosis: The ‘black fungus’ maiming Covid patients in India

Global Guideline for the Diagnosis and Management of Mucormycosis

 


Severe hearing loss in adults: finding out whether cochlear implants or hearing aids are better.

16 Jul, 2021 | 10:27h | UTC

Severe hearing loss in adults: finding out whether cochlear implants or hearing aids are better – Evidently Cochrane Blog

 

Commentary on Twitter

 


Study Commentary: Decreased Antibiotic Use for Acute Otitis Media and Acute Sinusitis Following Implementation of Childhood PCV13 Immunization.

8 Jul, 2021 | 08:54h | UTC

Decreased Antibiotic Use for Acute Otitis Media and Acute Sinusitis Following Implementation of Childhood PCV13 Immunization – NEJM Journal Watch

Original study: Impact of the 13-valent pneumococcal conjugate vaccine on acute otitis media and acute sinusitis epidemiology in British Columbia, Canada – Journal of Antimicrobial Chemotherapy

 


Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations.

5 Jul, 2021 | 01:19h | UTC

Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations: Executive Summary –

Otolaryngology–Head and Neck Surgery

Commentary: AAO/HNS Issue Guideline for Opioid Use After Otolaryngologic Surgery – HealthDay

 


Study finds 96.1% of patients objectively recovered from anosmia 1 year after COVID-19 diagnosis.

28 Jun, 2021 | 09:49h | UTC

Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis – JAMA Network Open

Commentary: Did Covid-19 take your taste and smell? Here’s when they may return – CNN AND Lost Sense of Smell Returns for Almost All COVID Survivors – HealthDay

 


Review: Advances in the diagnosis and treatment of primary ciliary dyskinesia.

21 Jun, 2021 | 08:27h | UTC

Advances in the Diagnosis and Treatment of Primary Ciliary Dyskinesia: A Review – JAMA Otolaryngology – Head & Neck Surgery (free for a limited period)

 


RCT: Tympanostomy-tube placement does not reduce episodes of acute otitis media among children 6 to 35 months of age with recurrent acute otitis media

13 May, 2021 | 05:57h | UTC

Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media – New England Journal of Medicine

Commentary: No lasting benefit to tubes over antibiotics for childhood ear infections – University of Pittsburgh

 


Clinical Manifestation, Evaluation, and Rehabilitative Strategy of Dysphagia Associated With COVID-19

27 Apr, 2021 | 08:29h | UTC

Clinical Manifestation, Evaluation, and Rehabilitative Strategy of Dysphagia Associated With COVID-19 – American Journal of Physical Medicine & Rehabilitation

 


Study shows antihistamines may impair response to exercise training

16 Apr, 2021 | 06:06h | UTC

Histamine H1 and H2 receptors are essential transducers of the integrative exercise training response in humans – Science Advances

Commentary: Histamine-suppressing drugs found to reduce benefits of exercise – MedicalXpress

 

Commentary on Twitter (thread – click for more)

 


COVID associated with hearing loss, tinnitus and vertigo – new study confirms link

30 Mar, 2021 | 03:19h | UTC

COVID associated with hearing loss, tinnitus and vertigo – new study confirms link – The Conversation

Original study: One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms – International Journal of Audiology

 


USPSTF Statement: Current evidence is insufficient to recommend screening for hearing loss in older adults

24 Mar, 2021 | 08:12h | UTC

Screening for Hearing Loss in Older Adults – U.S. Preventive Services Task Force

Editorial: Screening for Hearing Loss in Older Adults: Insufficient Evidence Does Not Mean Insufficient Benefit – JAMA AND United States Preventive Services Task Force Recommendation for Hearing-Loss Screening Among Older Adults: An Opportunity in Insufficient Evidence – AMA Otolaryngology-Head & Neck Surgery AND USPSTF Recommendations for Hearing Loss Screening in Asymptomatic Older Adults—A Case of Missing Evidence and Missing Treatment Options – JAMA Network Open

Evidence Report: Screening for Hearing Loss in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Author interview: USPSTF Recommendation: Screening for Hearing Loss in Older Adults – JAMA

JAMA Patient Page: Screening for Hearing Loss in Older Adults

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.